updates in the treatment of r/r lbcl: promising novel agents in the pipeline
Published 1 year ago • 56 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
3:46
the evolving treatment landscape of r/r lbcl
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
1:32
shifting the treatment landscape of itp: novel agents and future outlooks
-
6:44
the current landscape for the treatment of r/r aml in the post-transplant setting
-
1:16
how novel immunotherapies have impacted the treatment of r/r all
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
4:23
newer treatment options in pv and how the therapeutic landscape is evolving
-
50:47
covid & plasma - naturally improve platelet count levels
-
1:08:49
august 22, 2024 vmr with rabih & ethan - fever and sob
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
2:17
updates on the flt3 inhibitor ff-10101 for the treatment of r/r aml
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
1:32
assessing the dynamics of cd8-expressing cells in patients with r/r lbcl treated with glofitamab
-
2:15
updates from the phase ii aern trial: nivolumab and radiotherapy for the treatment of r/r hl
-
1:37
a prospective trial of radiation-free chemotherapy in high- and low-risk hl
-
2:08
hematological response to frontline treatment in lr-mds is associated with better os
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
3:55
updates in newly diagnosed and r/r aml
-
5:16
the evolution of al amyloidosis therapy
-
2:25
key ebmt guideline updates for the treatment and prophylaxis of gvhd
-
0:41
isct in bringing together the scientific community
-
2:15
hovon/llpc transplant brave: novel salvage chemotherapy for r/r hodgkin lymphoma